HealthTronics' OssaTron Lithotripter PMA Submission Will Focus On Heel Pain
This article was originally published in The Gray Sheet
Executive Summary
HealthTronics says it expects to submit a premarket approval application to FDA for the OssaTron orthopedic lithotripter by the end of the summer.
You may also be interested in...
HealthTronics OssaTron Lithotripter PMA Submission Planned By Year-End
A premarket approval application for HealthTronics' OssaTron lithotripter for treatment of chronic heel pain due to planar fasciitis should be submitted to FDA by December.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.